Local failure in resected N1 lung cancer: Implications for adjuvant therapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 2, 2012, Pages 727-733

  Higgins, Kristin A ^a   Chino, Junzo P ^a   Berry, Mark ^a   Ready, Neal ^a   Boyd, Jessamy ^b   Yoo, David S ^a   Kelsey, Chris R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Developmental Therapeutics Committee and Co Chair of the Genitourinary Committee   (United States)

Author keywords

Local failure; Lung cancer; N1; Postoperative radiotherapy

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; DUKE UNIVERSITY; HAZARD RATIO; KAPLAN-MEIER METHOD; LOCAL FAILURE; LOCAL RECURRENCE; LUNG CANCER; LYMPH NODE; MEDICAL CENTER; MULTI VARIATE ANALYSIS; N1; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PATHOLOGIC FACTORS; POSITIVE SURGICAL MARGIN; POSTOPERATIVE RADIOTHERAPY; TIME INTERVAL;

BIOLOGICAL ORGANS; BODY FLUIDS; CHEMOTHERAPY; DISEASES; MULTIVARIANT ANALYSIS; PATHOLOGY; RADIOTHERAPY;

SURGERY;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NORTH CAROLINA; PLEURA; THORACIC SURGERY, VIDEO-ASSISTED; TREATMENT FAILURE;

EID: 84861097254     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.07.018     Document Type: Article

References (29)

1. R. Arriagada, B. Bergman, and A. Dunant Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360 (Pubitemid 38101630)
2. J.Y. Douillard, R. Rosell, and M. De Lena Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial Lancet Oncol 7 2006 719 727 (Pubitemid 44283661)
3. T. Winton, R. Livingston, and D. Johnson Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2005 2589 2597 (Pubitemid 41007845)
4. J.P. Pignon, H. Tribodet, and G.V. Scagliotti Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
5. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group Lancet 352 1998 257 263
6. American Joint Committee on Cancer Cancer staging manual - lung 7th ed. 2010 Springer New York
7. C.R. Kelsey, K.L. Light, and L.B. Marks Patterns of failure after resection of non-small-cell lung cancer: Implications for postoperative radiation therapy volumes Int J Radiat Oncol Biol Phys 65 2006 1097 1105
8. E. Hata, K. Hayakawa, and H. Miyamoto Rationale for extended lymphadenectomy for lung cancer Theoretical Surgery 5 1990 19 25 (Pubitemid 20135444)
9. H.C. Nohl-Oser An investigation of the anatomy of the lymphatic drainage of the lungs as shown by the lymphatic spread of bronchial carcinoma Ann R Coll Surg Engl 51 1972 157 176
10. D. Collett Modeling survival data in medical research 2nd Ed. 2003 Chapman & Hall London
11. T.M. Therneau, and P.M. Grambsch Modeling survival data 2000 Springer New York
12. C.R. Kelsey, L.B. Marks, and L.D. Wilson Postoperative radiation therapy for lung cancer: Where do we stand? Oncology (Williston Park) 22 2008 301 310 discussion 310, 314-305, 319
13. T.E. Sawyer, J.A. Bonner, and P.M. Gould Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma Ann Thorac Surg 68 1999 1171 1176
14. D. Lardinois, H. Suter, and H. Hakki Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer Ann Thorac Surg 80 2005 268 274 discussion 274-265
15. S.C. Immerman, R.M. Vanecko, and W.A. Fry Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure Ann Thorac Surg 32 1981 23 27 (Pubitemid 11064491)
16. L. Luzzi, L. Voltolini, and A. Campione Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: Could the type of surgical resection dictate survival? J Cardiovasc Surg (Torino) 44 2003 119 123 (Pubitemid 36527380)
17. Y.T. Kim, C.H. Kang, and S.W. Sung Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy Ann Thorac Surg 79 2005 1153 1161 discussion 1153-1161 (Pubitemid 40431832)
18. Q.F. Feng, M. Wang, and L.J. Wang A study of postoperative radiotherapy in patients with non-small-cell lung cancer: A randomized trial Int J Radiat Oncol Biol Phys 47 2000 925 929 (Pubitemid 30345589)
19. C.P. Hsu, J.Y. Hsia, and G.C. Chang Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: A heterogeneous disease J Thorac Cardiovasc Surg 138 2009 426 433
20. A. Yilmaz, S.S. Duyar, and E. Cakir Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer Eur J Cardiothorac Surg 40 2011 664 670
21. M.J. Schuchert, L. Schumacher, and A. Kilic Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer Ann Thorac Surg 91 2011 1059 1065
22. J.M. Varlotto, L.N. Medford-Davis, and A. Recht Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer Int J Radiat Oncol Biol Phys 81 2011 353 359
23. T. Osaki, A. Nagashima, and T. Yoshimatsu Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer Lung Cancer 43 2004 151 157 (Pubitemid 38114743)
24. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622 discussion 622-613
25. S. Paul, N.K. Altorki, and S. Sheng Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database J Thorac Cardiovasc Surg 139 2010 366 378
26. J.Y. Douillard, R. Rosell, and M. De Lena Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial Int J Radiat Oncol Biol Phys 72 2008 695 701
27. B.E. Lally, D. Zelterman, and J.M. Colasanto Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database J Clin Oncol 24 2006 2998 3006 (Pubitemid 46638932)
28. M. Saunders, S. Dische, and A. Barrett Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial. CHART Steering Committee Lancet 350 1997 161 165 (Pubitemid 27303621)
29. A. Auperin, C. Le Pechoux, and E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190